Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18675,774,0.56 [0.47-0.67],6.841970783564466e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23269,931,0.59 [0.51-0.69],1.0474637218120724e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26477,420,0.40 [0.32-0.50],3.916242002523897e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26468,411,0.39 [0.31-0.49],1.7331916198617227e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23072,734,0.60 [0.50-0.71],1.406039235899201e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,23019,681,0.57 [0.48-0.69],2.9013141677123724e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,23652,630,0.73 [0.60-0.88],0.0011869515537262
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,24178,1664,0.76 [0.67-0.85],5.204743577596495e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20640,2843,0.69 [0.62-0.76],2.5949719137508426e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21681,2093,0.62 [0.55-0.69],6.77633246896399e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,21703,2115,0.62 [0.55-0.69],3.3997716006847216e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26346,739,0.76 [0.63-0.90],0.0017579994926233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,26120,513,0.76 [0.61-0.93],0.0086282999737514
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26081,486,0.67 [0.54-0.83],0.0002806705370342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22793,2136,0.77 [0.69-0.86],2.510810672611788e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25041,1186,0.70 [0.61-0.81],9.424671540646732e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,26972,161,0.56 [0.39-0.80],0.0013803205203243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26992,181,0.61 [0.44-0.86],0.0044309558526814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26992,181,0.61 [0.44-0.86],0.0044309558526814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25962,1020,0.74 [0.64-0.86],7.728492426535071e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,20839,1020,0.66 [0.57-0.78],2.1436782890959646e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20645,1020,0.66 [0.57-0.77],1.897777013658711e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20824,1005,0.66 [0.57-0.78],2.401241911471072e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27726,83,0.39 [0.25-0.61],4.954663878557668e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,26230,62,0.33 [0.20-0.57],5.203024568001166e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27802,62,0.36 [0.22-0.60],8.628611437489234e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26223,55,0.34 [0.19-0.60],0.0002006142898719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6113,0.82 [0.76-0.89],3.194323847178212e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21198,224,0.58 [0.43-0.79],0.0004675192631624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23331,2357,0.81 [0.73-0.90],9.214834948207072e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,21122,148,0.60 [0.41-0.87],0.0076744635514884
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21836,862,0.76 [0.64-0.89],0.0008013639391127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21155,181,0.57 [0.41-0.80],0.0013033658883808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,25116,1223,0.77 [0.67-0.88],0.0001545451950815
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24871,978,0.77 [0.66-0.89],0.0006532247364571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,22214,2232,0.86 [0.78-0.96],0.0067782246603517
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27702,64,0.48 [0.27-0.83],0.0085838609657857
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27985,93,0.39 [0.25-0.61],3.285159886520531e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,26118,93,0.39 [0.25-0.61],2.8630237224851425e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26093,68,0.49 [0.29-0.84],0.0098119004858811
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20663,681,0.64 [0.53-0.77],2.4100269009478e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,27250,107,0.48 [0.32-0.73],0.0006623323911841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26449,898,0.78 [0.67-0.92],0.0024115861476602
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26496,171,0.60 [0.42-0.84],0.0033216478856891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,26486,161,0.60 [0.42-0.86],0.0053169000797544
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24827,1648,0.80 [0.71-0.91],0.0003765938391146
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27586,464,0.73 [0.59-0.90],0.0040239749444926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27180,58,0.45 [0.25-0.78],0.0045194281154918
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19751,4487,0.86 [0.79-0.93],0.0002734695126252
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21523,2585,0.87 [0.79-0.97],0.0095884761143451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19465,527,0.75 [0.61-0.92],0.0062528671784619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19434,496,0.73 [0.59-0.90],0.0041926605848703
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27212,223,0.61 [0.44-0.83],0.0018344089871792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27083,94,0.47 [0.30-0.75],0.0016121741739904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22888,6224,0.90 [0.83-0.96],0.0022422729109227
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25544,204,0.63 [0.46-0.87],0.0051168796022463
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25733,49,0.35 [0.20-0.61],0.0002246777577837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25784,1275,0.83 [0.72-0.95],0.0066932976570291
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27736,485,1.35 [1.09-1.68],0.0067681942685759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21719,806,0.79 [0.67-0.93],0.0052759976928488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21104,191,0.61 [0.44-0.86],0.0043650081078977
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,888,1.35 [1.13-1.62],0.0009982809218422
